Formulation and In Vitro Evaluation of Ceftriaxone Sodium Coated Suture for Antibacterial Activity
International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN) · 15.04.2026 · 19 (2) · 8602-8607
DOI: 10.37285/ijpsn.2026.19.2.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN), online erschienen am 15.04.2026. Verfasst von Sankar V und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
The purpose of this study is to determine the antibacterial efficacy of sutures coated with ceftriaxone sodium.
Background
The use of advanced antibiotics in the postoperative recovery phase has become increasingly common as a way to manage and prevent infections. Localized antibiotic treatment, rather than systemic administration, is particularly crucial for avoiding severe side effects, especially in patients with underlying health conditions such as cardiac or renal disease. Delivering antibiotics directly at the site of infection reduces the risks of complications, making it an effective strategy for vulnerable patients.
Objective
The primary goal of this research was to apply ceftriaxone sodium to both custom-made and commercially available sutures and to evaluate their antibacterial properties along with the in vitro release characteristics of the drug.
Method
Ceftriaxone sodium was applied to both specially prepared sutures and standard commercial sutures. Using a water-bath extrusion approach, a 40% solution of poly(lactic-co-glycolic acid) was employed to produce a monofilament suture. To evaluate the antibacterial properties, an agar diffusion assay was conducted using common bacterial strains responsible for common postoperative wound pathogens, including Staphylococcus aureus and Escherichia coli. The results from the ceftriaxone-coated prepared sutures were compared with those from commercial sutures also coated with ceftriaxone sodium. The sutures were coated using a dip-coating approach, and their surface structure was analyzed with scanning electron microscopy (SEM).
Results
PLGA sutures were found to be slightly thinner at 22 µm, compared to the marketed sutures' 35 µm thickness. At 0.47 mg/cm², the amount of ceftriaxone sodium adsorbed on the suture surface was found. When PLGA sutures were subjected to pH 7.4 phosphate-buffered saline for 45 minutes, 38.7% of the drug was released from them, according to in vitro drug release experiments.
Conclusion
The ceftriaxone-coated Vicryl multifilament sutures demonstrated superior drug release and antibacterial potential against S. aureus and E. coli compared to the PLGA monofilament sutures. These findings suggest that the marketed sutures provide better performance in terms of both drug release and antibacterial activity
Zitieren
APA
V, S., S, P. R., M, N., N, J., & A, J. (2026). Formulation and In Vitro Evaluation of Ceftriaxone Sodium Coated Suture for Antibacterial Activity. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN), 19(2), 8602-8607. https://doi.org/10.37285/ijpsn.2026.19.2.3
Vancouver
V S, S PR, M N, N J, A J. Formulation and In Vitro Evaluation of Ceftriaxone Sodium Coated Suture for Antibacterial Activity. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN). 2026;19(2):8602-8607. doi:10.37285/ijpsn.2026.19.2.3
BibTeX
@article{V2026,
author = {V, Sankar and S, Pranav Ragavendra and M, Nithyanth and N, Jawahar and A, Justin},
title = {Formulation and In Vitro Evaluation of Ceftriaxone Sodium Coated Suture for Antibacterial Activity},
journal = {International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN)},
year = {2026},
volume = {19},
number = {2},
pages = {8602--8607},
doi = {10.37285/ijpsn.2026.19.2.3}
}
EUVIMED